Press release
Meticulous Research® Unveils In-Depth Report on the Cancer/Tumor Profiling Market Forecasting Growth to $24.70 Billion by 2031
Meticulous Research®, a leading global market intelligence firm, has published its latest comprehensive report titled "Cancer/Tumor Profiling Market Size, Share, Forecast, & Trends Analysis by Biomarker Type (Genetic, Protein), Technology (NGS, PCR, ISH), Cancer Type (Breast, Prostate), Application (Clinical, Research), End User (Pharma, Academic) - Global Forecast to 2031."Download Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5630
The report provides a detailed analysis of the global cancer/tumor profiling market, highlighting its significant growth trajectory. According to the findings, the market is expected to reach a valuation of $24.70 billion by 2031, with a robust compound annual growth rate (CAGR) of 10.9% over the forecast period.
Key Drivers Fueling Market Growth
The rising prevalence of cancer worldwide remains the primary catalyst for the growth of the cancer/tumor profiling market. Additional factors contributing to this expansion include increasing pharmaceutical R&D investments, the surge in targeted therapies, and the discovery of actionable biomarkers. Moreover, advancements in multi-omics tumor profiling and the declining costs associated with next-generation sequencing (NGS) are further accelerating market growth.
However, market growth is constrained by challenges such as the high capital investment required for NGS technology and prolonged turnaround times for test results. Despite these obstacles, the increasing focus on personalized medicine and the growing adoption of targeted therapies present promising opportunities for market players.
Market Segmentation & Key Insights
The cancer/tumor profiling market is segmented based on biomarker type, technology, cancer type, application, end user, and geography. The report provides a granular analysis of these segments:
Browse in Depth: https://www.meticulousresearch.com/product/cancer-tumor-profiling-market-5630
• Biomarker Type: In 2024, the genetic biomarkers segment is anticipated to dominate the market, accounting for 72% of the total share. This is due to the rising demand for molecular insights into cancer, the growing use of gene-based analyses in clinical care, and the widespread adoption of genetic biomarker testing in determining treatment pathways.
• Technology: Next-generation sequencing (NGS) is projected to hold the largest market share in 2024. NGS offers superior sensitivity for variant detection and reduced sequencing costs, making it a preferred technology for cancer profiling.
• Cancer Type: Among cancer types, breast cancer is expected to lead the market in 2024. Factors such as the increasing incidence of breast cancer, governmental initiatives supporting breast cancer research, rising healthcare expenditures, and reimbursement for technologies like NGS are driving this segment's growth.
• Application: The research applications segment is forecasted to capture the largest share of the market by 2024, fueled by the growing incidence of cancer, the demand for precision medicine, and advancements in biomarker discovery.
• End User: Pharmaceutical and biopharmaceutical companies are poised to dominate the end-user segment, with a 40.9% market share in 2024. Their increasing focus on genomic research, cost-effective sequencing, and precision medicine initiatives are key factors driving this dominance.
Regional Insights
In terms of geography, North America is expected to maintain its leading position in the cancer/tumor profiling market, accounting for 42.7% of the total market share by 2024. This growth is supported by the region's high cancer incidence rates, increased R&D funding, growing demand for precision medicine, and government initiatives that foster cancer research. Europe and Asia-Pacific follow North America in terms of market share, with significant growth potential in emerging markets.
Quick Buy @ https://www.meticulousresearch.com/Checkout/81920399
Leading Market Players
The competitive landscape of the cancer/tumor profiling market is shaped by prominent companies including Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), NanoString Technologies, Inc. (U.S.), HTG Molecular Diagnostics, Inc. (U.S.), Agendia Inc. (U.S.), Personalis, Inc. (U.S.), Exact Sciences Corporation (U.S.), and Tempus Labs, Inc. (U.S.). These companies are driving innovation in cancer profiling through continuous research and development efforts, strategic partnerships, and acquisitions aimed at enhancing their product portfolios and expanding their market reach.
Related Reports:
Europe Cancer Diagnostics Market - https://www.meticulousresearch.com/product/europe-cancer-diagnostics-market-5787
Point of care Diagnostics Market - https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871
In-vitro Diagnostics Market - https://www.meticulousresearch.com/product/ivd-market-4858
IVD Reagents Market - https://www.meticulousresearch.com/product/ivd-reagents-market-5110
Medical Imaging Market - https://www.meticulousresearch.com/product/medical-imaging-market-4950
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email-
sales@meticulousresearch.com
Visit Our Website:
https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meticulous Research® Unveils In-Depth Report on the Cancer/Tumor Profiling Market Forecasting Growth to $24.70 Billion by 2031 here
News-ID: 3651345 • Views: …
More Releases from Meticulous Research®
AI-Powered Driver Monitoring Systems Market 2026-2036: Growth, Trends, and Forec …
The global market for AI-powered driver monitoring systems is expected to expand steadily during the forecast period from 2026 to 2036. Market value is estimated at USD 2.14 billion in 2026 and is projected to reach USD 12.87 billion by 2036, representing a compound annual growth rate (CAGR) of 19.4%. Growth is linked to increased implementation of driver safety monitoring requirements and broader adoption of advanced driver assistance technologies. Driver…
Global Ebb and Flow System Market: Growth Outlook, Trends, and Opportunities (20 …
The ebb and flow system market is growing fast. In 2026, the market is estimated at around USD 1.4 billion, and by 2036, it is expected to hit USD 4.6 billion. This means a healthy growth rate of about 12.4% per year. Ebb and flow, also called flood and drain systems, work in a simple but effective way. They flood plant roots with nutrient solution and then drain it back…
AI Designs the Runway: Fashion Market Set to Hit $75.9 Billion by 2035
The fashion industry is experiencing its most radical transformation since the sewing machine. Artificial intelligence isn't just assisting designers-it's creating entire collections, generating virtual garments, and personalizing fashion at a scale that was unimaginable a few years ago.
According to new research from Meticulous Research®, the global AI-generated fashion market reached $2.14 billion in 2024 and is projected to soar to $75.9 billion by 2035, growing at a remarkable 38.6% annually.…
Global Autonomous AI and Autonomous Agents Market to Reach USD 477.8 Billion by …
Artificial intelligence is entering a new phase. Instead of tools that need constant human direction, we're now seeing AI systems that perceive their environment, make decisions, and take action independently. And the numbers are staggering. According to new research from Meticulous Research®, the global autonomous AI and autonomous agents market reached $7.91 billion in 2024 and is projected to explode to $477.8 billion by 2035-growing at an extraordinary 45.2% annually.…
More Releases for NGS
Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market.
Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective…
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report.
Global Next-Generation Sequencing (NGS) Services Market,…
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379
The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home.
Top Companies Analysis -
Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter
F. Hoffmann-La Roche AG
Illumina, Inc.
…
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504
This latest report researches the industry structure,…
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of…
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers…
